CF PharmTech

OverviewSuggest Edit

CF PharmTech (长风药业股份有限公司) is a specialty pharmaceutical company focused on the development and manufacturing of inhalation products. Its offerings include HFA-based metered dose inhalers, nasal sprays, nebulized and dry powder products for respiratory diseases, etc.

HQSuzhou Shi, CN

Latest Updates

Employees (est.) (Jan 2021)27
Cybersecurity ratingBMore

Key People/Management at CF PharmTech

Bill Liang

Bill Liang

Jean-Marc Bovet

Jean-Marc Bovet

Show more

CF PharmTech Office Locations

CF PharmTech has offices in Suzhou Shi, Nanjing Shi, Wuxi Shi and City of Industry
Suzhou Shi, CN (HQ)
Hu Cun Dang Lu, Xiangcheng Qu
Nanjing Shi, CN
Xing Ke Lu, Qixia Qu
Wuxi Shi, CN
99 Jinxi Rd, Binhu Qu
City of Industry, CA, US
16714 E Johnson Dr
Show all (4)

CF PharmTech Financials and Metrics

Summary Metrics

Founding Date


CF PharmTech total Funding

$205.4 m

CF PharmTech latest funding size

$50 m

Time since last funding

7 months ago

CF PharmTech investors

CF PharmTech's latest funding round in July 2020 was reported to be $50 m. In total, CF PharmTech has raised $205.4 m
Show all financial metrics

CF PharmTech Operating Metrics

Jan, 2020Oct, 2020

Facility Space, sq. m

15.70 k



R&D Facility Space, sq. m.

3 k
Show all operating metrics

CF PharmTech Acquisitions / Subsidiaries

Company NameDateDeal Size
Jiangsu CF Pharmaceutical Co., Ltd.
Nanjing CF Pharmaceutical Technology Co., Ltd.

CF PharmTech Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

CF PharmTech Online and Social Media Presence

Embed Graph

CF PharmTech News and Updates


CF PharmTech Raises $65M in Series D Financing

CF PharmTech Raises $65M in Series D FinancingCF PharmTech, Inc., a Suzhou, China-based specialty pharmaceutical company that develops and manufactures inhalation products, raised $65M in Series D financing.

China’s CF PharmTech bags $50m in Series F round

Chinese respiratory disease-focused pharmaceutical company CF PharmTech, Inc on Thursday said it has raised 360 million yuan ($50 million) in a Series F round of financing from healthcare-focused BioTrack Capital, CICC Capital’s CICC Qichen, CICC Qide, SAIC Hengxu, GP M&A Fund and Watson Investm…

China’s CF PharmTech raises $90m Series E led by New Alliance Capital

Chinese pharma company CF PharmTech, Inc has raised $90 million in its Series E round led by New Alliance Capital, according to a statement. The round saw participation from CR-CP Life Science Fund, Finnova Capital, GT Capital, Co-stone Asset Management, Xiangcheng Financial Holdings and Everest Ve…

CF PharmTech Frequently Asked Questions

  • When was CF PharmTech founded?

    CF PharmTech was founded in 2007.

  • Who are CF PharmTech key executives?

    CF PharmTech's key executives are Bill Liang and Jean-Marc Bovet.

  • How many employees does CF PharmTech have?

    CF PharmTech has 27 employees.

  • Who are CF PharmTech competitors?

    Competitors of CF PharmTech include Neuronasal, BioFactura and Rigvir.

  • Where is CF PharmTech headquarters?

    CF PharmTech headquarters is located at Hu Cun Dang Lu, Xiangcheng Qu, Suzhou Shi.

  • Where are CF PharmTech offices?

    CF PharmTech has offices in Suzhou Shi, Nanjing Shi, Wuxi Shi and City of Industry.

  • How many offices does CF PharmTech have?

    CF PharmTech has 4 offices.